FOLH1 and posterior cortical atrophy: These findings require further confirmation in vitro and in vivo experiments to study the exact molecular mechanisms associated with the growth-inhibitory effects of PSMA-617 observed in PCa cells in order to test the potential of the simultaneous treatment with PSMA-617 and 177Lu-PSMA-617 for the translation in a clinical trial.